The role of hypoxia-inducible factor-1α and vascular endothelial growth factor in late-phase preconditioning with xenon, isoflurane and levosimendan in rat cardiomyocytes

Interactive Cardiovascular and Thoracic Surgery

Volumn 18, Issue 3, 2014, Pages 321-328

  Goetzenich, Andreas ^a   Hatam, Nima ^a   Preuss, Stephanie ^a   Moza, Ajay ^a   Bleilevens, Christian ^a   Roehl, Anna B ^a   Autschbach, Rüdiger ^a   Bernhagen, Jürgen ^a   Stoppe, Christian ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Anaesthetics; Hypoxia; Myocardial preconditioning

Indexed keywords

CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOFLURANE; LEVOSIMENDAN; MESSENGER RNA; METOPROLOL; VASCULOTROPIN; XENON;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL HYPOXIA; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; COX 2 GENE; ENOS GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; HIF 1ALPHA GENE; HIF 2ALPHA GENE; INOS GENE; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; VEGF GENE; WESTERN BLOTTING;

ANAESTHETICS; HYPOXIA; MYOCARDIAL PRECONDITIONING;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; HYDRAZONES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISOFLURANE; METOPROLOL; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE II; PYRIDAZINES; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENON;

EID: 84894677393     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivt450     Document Type: Article

References (24)

1. Hausenloy DJ, Yellon DM. The second window of preconditioning (SWOP) where are we now? Cardiovasc Drugs Ther 2010;24:235-54.
2. Goetzenich A, Roehl AB, Moza A, Srecec D, Beyer C, Arnold S et al. The effects of metoprolol on hypoxia- and isoflurane-induced cardiac latephase preconditioning. Acta Anaesthesiol Scand 2011;55:862-9.
3. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 2000;68:106-14.
4. Hansen A, Eder A, Bönstrup M, Flato M, Mewe M, Schaaf S et al. Development of a drug screening platform based on engineered heart tissue. Circ Res 2010;107:35-44.
5. du Toit EF, Genis A, Opie LH, Pollesello P, Lochner A. A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart. Br J Pharmacol 2008;154: 41-50.
6. Ma D, Lim T, Xu J, Tang H, Wan Y, Zhao H et al. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol 2009;20:713-20.
7. Hieber S, Huhn R, Hollmann MW, Weber NC, Preckel B. Hypoxiainducible factor 1 and related gene products in anaesthetic-induced preconditioning. Eur J Anaesthesiol 2009;26:201-6.
8. Kim C-H, Cho Y-S, Chun Y-S, Park J-W, Kim M-S. Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res 2002;90:E25-33.
9. Wang C, Weihrauch D, Schwabe DA, Bienengraeber M, Warltier DC, Kersten JR et al. Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats. Anesth Analg 2006;103:281-8. Table of contents.
10. Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000;102: 3098-103.
11. Jaffer FA, Sosnovik DE, Nahrendorf M, Weissleder R. Molecular imaging of myocardial infarction. J Mol Cell Cardiol 2006;41:921-33.
12. Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR et al. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. Anesthesiology 2004; 100:525-31.
13. Lange M, Smul TM, Blomeyer CA, Redel A, Klotz K-N, Roewer N et al. Role of the beta1-adrenergic pathway in anesthetic and ischemic preconditioning against myocardial infarction in the rabbit heart in vivo. Anesthesiology 2006;105:503-10.
14. Das DK, Maulik N. Cardiac genomic response following preconditioning stimulus. Cardiovasc Res 2006;70:254-63.
15. Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L. Activation of hypoxia-inducible factor 1α: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci 1997;94:5667-72.
16. Bencsik P, Kupai K, Giricz Z, Görbe A, Pipis J, Murlasits Z et al. Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats. Am J Physiol Heart Circ Physiol 2010;299:H512-8.
17. Kim S-J, Malik G, Saad MM, Yoon S-H, Gonzalez JB, Crystal GJ. Nitric oxide has no obligatory role in isoflurane late preconditioning against myocardial stunning. Life Sci 2012;91:1201-6.
18. Das B, Sarkar C. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model. Vascul Pharmacol 2007;47:248-56.
19. Haessler R, Kuzume K, Chien GL, Wolff RA, Davis RF, Van Winkle DM. Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning. Cardiovasc Res 1994;28:1574-80.
20. Yellon DM, Baxter GF. A 'second window of protection' or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol 1995;27:1023-34.
21. Patel HH, Hsu AK, Gross GJ. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat. Life Sci 2004;75:129-40.
22. Roehl AB, Zoremba N, Kipp M, Schiefer J, Goetzenich A, Bleilevens C et al. The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia/hypoxia. BMC Neurol 2012;12:81.
23. Soeding PF, Crack PJ, Wright CE, Angus JA, Royse CF. Levosimendan preserves the contractile responsiveness of hypoxic human myocardium via mitochondrial K(ATP) channel and potential pERK 1/2 activation. Eur J Pharmacol 2011;655:59-66.
24. Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury-a review. J Surg Res 2008;150:304-30.